Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy

Detalles Bibliográficos
Autores principales: Guo, Tianxing, Wang, Zhaofeng, Wang, Song, Zhang, Yaru, Pang, Jiaohui, Ying, Yajun, Ou, Qiuxiang, Shen, Dong, Li, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letter to the Journal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545889/
https://www.ncbi.nlm.nih.gov/pubmed/37784247
http://dx.doi.org/10.1002/ctm2.1430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545889/
https://www.ncbi.nlm.nih.gov/pubmed/37784247
http://dx.doi.org/10.1002/ctm2.1430

Ejemplares similares